Regencell Bioscience Holdings Limited (NASDAQ:RGC - Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $14.50, but opened at $14.00. Regencell Bioscience shares last traded at $13.88, with a volume of 145,000 shares.
Regencell Bioscience Stock Performance
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Regencell Bioscience stock. Greenfield Savings Bank purchased a new stake in shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 11,000 shares of the company's stock, valued at approximately $187,000. 0.13% of the stock is currently owned by hedge funds and other institutional investors.
Regencell Bioscience Company Profile
(
Get Free Report)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
